FDA Approves Kuvan For Phenylketonuria Treatment
FDA approved Kuvan (sapropterin dihydrochloride), the first drug of its kind approved to slow the effects of a rare genetic disorder that causes mental retardation.
|
AARP Benefits Financially From Medicare Prescription Drug Benefit
Some advocates have expressed concern over the commercial success of AARP-branded Medicare prescription drug plans.
|
Cosmetic Dentistry Continues To Surge
The cosmetic dental boom is showing no signs of slowing down.
|
HHS Reacts To Court Ruling On Medicaid Reimbursements For Generic Drugs
HHS is seeking to limit the scope of a judge's decision last week to temporarily halt Medicaid from implementing a new formula for drug reimbursements to pharmacies.
|
FDA Grants Approval To First Generic For Antiretroviral Viread
FDA has issued a tentative approval for a generic version of Viread.
|
EC Approves Gilead, BMS, Merck Antiretroviral Atripla
European Commission approved the once-daily antiretroviral drug Atripla.
|
Insmed Receives Orphan Drug Designation For IPLEX
FDA has granted Orphan Drug Designation for Insmed's IPLEX for the treatment of Myotonic Muscular Dystrophy (MMD).
|
Initiatives Target Lowering Drug Utilization For Tennessee Residents
Tennessee may have the highest drug utilization rate in the country, but initiatives within the state are working to push the state off this top spot.
|
Many Osteoporosis Medications Prevent Fractures, But None Is Proven Best
Many medications reduce the risk of bone fractures in people with osteoporosis, but the most commonly used drugs have not been proven more effective than alternatives.
|
Judge Grants Preliminary Injunction Against Rule That Would Revise Medicaid AMP For Rx Drugs
U.S District Court Judge granted a preliminary injunction that prohibits HHS from adopting a new method for calculating the average manufacturer price for prescription drugs covered by Medicaid.
|
Restrictions On Promotion Of Off-Labe Medication Uses Raise Concerns
Efforts to confine patients and doctors to uses of medications through restrictions on the promotion of treatments for off-label uses by pharmaceutical companies raise the questions.
|
Prescription for an electronic revolution?
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
|
Preventing Winter Sports Injuries
While winter sports may be especially fun for kids, serious injury can happen quickly if proper precaution is not used.
|
FMC, Pronova BioPharma To Develop New Alginate-Based Capsule Products
FMC, Pronova to develop alginate-based capsule products using a novel technology developed by FMC.
|
FDA Revises Warning Labels On Certain Epilepsy Drugs
FDA announced revisions to the labels of certain epilepsy, bipolar disorder and nerve pain medications.
|
FDA Panel Rejects Merck Statin Mevacor
FDA voted against recommending that Merck's cholesterol drug Mevacor be granted over-the-counter status.
|
Pharmacists Needed to Guide Use of Nonprescription Statins
The Food and Drug Administration (FDA) should explore alternative models for dispensing HMG co-reductase inhibitors, or statins, instead of reclassifying the medications to over-the-counter status.
|
Generic Prescription Drugs Show Greater Use In Southeastern Pennsylvania
Generic prescription drug use is on the rise and more and more people are learning about the effectiveness, safety and cost saving benefits of generics.
|
A Better Smile Can Revive At Any Age
Soraino, a former Army paratrooper and ski instructor, visited Dr. Shila Yazdani, a dentist specializing in neuromuscular and cosmetic dentistry, to have his smile reconstructed.
|
Seniors Unable To Afford Prescription Drugs
Two-thirds of California seniors cannot afford their medications, and nine in 10 seniors want to be able to choose which medications are prescribed to them.
|
KFF Examines Medicare Prescription Drug Benefit
Kaiser Family Foundation releases resources about Medicare prescription drug benefit.
|
Nearly 700 New Medications In Development To Treat Diseases Affecting Blacks
Drug companies are working on 691 new medicines that treat diseases disproportionately affecting blacks.
|
Tips For Beating The Seasonal Blues
During the winter, and especially around the holidays, many people find themselves becoming more sad, lonely, depressed or anxious than at any other time of year.
|
FDA's Reviews of Prilosec and Nexium: No Heart Attack Risk Increase
FDA says it's review of Prilosec and Nexium shows there is no evidence of increased risk of heart attack.
|
Political Developments Could Encourage Broader Use Of E-Prescribing
SureScripts operates a network that allows physicians to send prescriptions to pharmacies through the Internet for a processing fee of up to 21 cents per transaction.
|
GlaxoSmithKline Withdraws Patent Applications For Antiretrovirals
GlaxoSmithKline recently withdrew the patent applications for its antiretroviral drugs Abacavir and Trizivir in India.
|
CDX-110: Novel EGFRvIII Vaccine For Glioblastoma Multiforme
FDA has granted orphan drug designation for Celldex's CDX-110 for the treatment of EGFRvIII expressing Glioblastoma Multiforme (GBM).
|
Grassley Seeks Probe On Antipsychotic Use In Nursing Homes
Chuck Grassley asked HHS to examine the use of antipsychotics in nursing homes.
|
Examining Challenges Drug Industry Will Face In Coming Years
In future years, some of the top-selling drugs in industry history will become history as patent protections expire.
|
Survey Shows Broad Support Among Americans For Pharmacy Technician Certification
Americans have strong misperceptions about the required qualifications of the people helping pharmacists prepare prescriptions in pharmacies.
|
Asacol Is Effective In Treating All Extents Of Ulcerative Colitis
Asacol, an oral, non-steroidal medication that belongs to the class of agents known as 5-aminosalicylic acids (5-ASAs), is an effective and well-tolerated treatment for patients with all extents of ulcerative colitis.
|
Nastech To Develop Non-Injectable Dosage Form Of Factor IX To Control Bleeding
Nastech Pharmaceutical to develop an alternative dosage form of Factor IX protein which is currently administered by injection to control and prevent bleeding in patients with hemophilia B.
|
FDA Approves Mylan's Generic Version Of Antiretroviral Viread
Mylan received tentative FDA approval for its generic version of Gilead Sciences' antiretroviral drug Viread.
|
Soliris Demonstrates Reductions In Hemolysis, Improvements In Fatigue
Soliris therapy reduced hemolysis and improved fatigue, overall quality of life and anemia in a diverse population of patients with a rare blood disorder called paroxysmal nocturnal hemoglobinuria.
|
Americans Prefer Root Canal Treatment By Endodontists
There may not be a more feared dental procedure than a root canal, but the key to ensuring a positive experience is choosing the right professional to perform the procedure.
|
FDA Approves PEPFAR For Tenofovir Disoproxil Fumarate Tablets
Matrix Laboratories has received tentative approval from FDA for its Abbreviated New Drug Application (ANDA) for Tenofovir Disoproxil Fumarate Tablets.
|
MRSA Facts For Handwashing Week
Association for Professionals in Infection Control and Epidemiology presents information on Methicillin-resistant Staphylococcus aureus (MRSA).
|
Nutrient Levels May Be Reduced For Americans Taking Prescription Medications
More than half of all Americans take prescription drugs, and most are unaware that they could have reduced levels of certain nutrients as a result.
|
FDA Launches E-mail Alert Subscription Service
FDA announced a new e-mail service that alerts subscribers whenever information is updated on certain FDA Web pages.
|
The Death of Pimp C Brings Up The Issue of Homicide in Black Men
Homicide and the review of black young men's homicide is in the attention of the national health medica as Pimp C of UGK Chad Butler is found dead in a hotel and the police is treating Pimp C's death as Homicide.
|
